EG20539A - Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure - Google Patents

Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure

Info

Publication number
EG20539A
EG20539A EG68994A EG68994A EG20539A EG 20539 A EG20539 A EG 20539A EG 68994 A EG68994 A EG 68994A EG 68994 A EG68994 A EG 68994A EG 20539 A EG20539 A EG 20539A
Authority
EG
Egypt
Prior art keywords
hydrogen
pct
blood pressure
chloro
methyl
Prior art date
Application number
EG68994A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG20539A publication Critical patent/EG20539A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
EG68994A 1993-11-05 1994-11-02 Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure EG20539A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303657A SE9303657D0 (sv) 1993-11-05 1993-11-05 Short-acting dihydropyridines

Publications (1)

Publication Number Publication Date
EG20539A true EG20539A (en) 1999-07-31

Family

ID=20391655

Family Applications (1)

Application Number Title Priority Date Filing Date
EG68994A EG20539A (en) 1993-11-05 1994-11-02 Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure

Country Status (36)

Country Link
US (1) US5856346A (ja)
EP (1) EP0726894B1 (ja)
JP (1) JP3712209B2 (ja)
KR (1) KR100331663B1 (ja)
CN (1) CN1049428C (ja)
AT (1) ATE194330T1 (ja)
AU (1) AU685532B2 (ja)
BR (1) BR9407946A (ja)
CA (1) CA2174969C (ja)
CZ (1) CZ285691B6 (ja)
DE (1) DE69425152T2 (ja)
DK (1) DK0726894T3 (ja)
EE (1) EE03230B1 (ja)
EG (1) EG20539A (ja)
ES (1) ES2150544T3 (ja)
FI (1) FI110429B (ja)
FR (1) FR12C0053I2 (ja)
GR (1) GR3034469T3 (ja)
HK (1) HK1013292A1 (ja)
HU (1) HU215591B (ja)
IL (1) IL111127A (ja)
IS (1) IS1674B (ja)
LU (1) LU92209I2 (ja)
MY (1) MY111770A (ja)
NO (1) NO305656B1 (ja)
NZ (1) NZ275915A (ja)
PL (1) PL185099B1 (ja)
PT (1) PT726894E (ja)
RU (1) RU2139278C1 (ja)
SA (1) SA94150250B1 (ja)
SE (1) SE9303657D0 (ja)
SK (1) SK281467B6 (ja)
TW (1) TW279859B (ja)
UA (1) UA45959C2 (ja)
WO (1) WO1995012578A1 (ja)
ZA (1) ZA947570B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
WO2003059193A2 (en) * 2001-12-21 2003-07-24 Alcon, Inc. Use of nanoparticles as carriers for biocides in ophthalmic compositions
FR2922439B1 (fr) * 2007-10-18 2010-12-10 Hill Rom Ind Sa Procede de gonflage alterne d'un dispositif de support a cellules gonflables et dispositif pour sa mise en oeuvre
BRPI0916936B8 (pt) 2008-08-01 2021-05-25 Chiesi Farm Spa composições farmacêuticas, uso de clevidipina e método de reduzir impurezas.
ES2543470T3 (es) * 2009-09-30 2015-08-19 Microdose Therapeutx, Inc. Métodos y composiciones para el tratamiento del fenómeno de Raynaud
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
CA2701087A1 (en) * 2010-04-12 2011-10-12 Alphora Research Inc. Preparation of clevidipine butyrate ring the same
US8455655B2 (en) 2010-05-07 2013-06-04 Laboratorios Lesvi, S.L. Preparation of dihydropyridines
EP2386544B1 (en) 2010-05-07 2016-02-10 Laboratorios Lesvi, S.L. Preparation of dihydropyridines
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
MX2013004151A (es) 2010-10-12 2013-05-20 Medicines Co Formulaciones de emulsion de clevidipina que contienen agentes antimicrobianos.
JP2014509654A (ja) * 2011-04-01 2014-04-21 ザ メディシンズ カンパニー 脳卒中損傷の低減に使用するための短時間作用型ジヒドロピリジン（クレビジピン）
CN103906508A (zh) 2011-08-26 2014-07-02 沃克哈特有限公司 治疗心血管疾病的方法
CN103420899B (zh) * 2012-05-25 2016-01-27 四川科伦药物研究有限公司 一种丁酸氯维地平的纯化方法
CN110840890A (zh) 2012-10-26 2020-02-28 凯西制药公司 用于在心力衰竭中控制血压和减轻呼吸困难的方法
CN103073485B (zh) * 2013-01-17 2015-09-02 北京嘉林药业股份有限公司 一种丁酸氯维地平的制备方法
CN103086956B (zh) * 2013-01-17 2015-11-04 北京嘉林药业股份有限公司 一种丁酸氯维地平中间体的纯化方法
CN106456617A (zh) 2014-05-19 2017-02-22 医药公司 氯维地平纳米颗粒及其药物组合物
CN105367487A (zh) * 2014-08-23 2016-03-02 南京海纳医药科技有限公司 一种丁酸氯维地平重要中间体新的合成方法
CN104370802A (zh) * 2014-09-24 2015-02-25 北京蓝丹医药科技有限公司 氯维地平衍生物及其制备方法
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP6943859B2 (ja) 2015-12-28 2021-10-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
RU2755349C1 (ru) * 2021-02-16 2021-09-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な１，４−ジヒドロピリジン化合物及びその製造方法

Also Published As

Publication number Publication date
FR12C0053I1 (ja) 2012-02-11
IS4218A (is) 1995-05-06
AU685532B2 (en) 1998-01-22
DK0726894T3 (da) 2000-10-23
SE9303657D0 (sv) 1993-11-05
AU8119694A (en) 1995-05-23
ES2150544T3 (es) 2000-12-01
EE03230B1 (et) 1999-10-15
DE69425152D1 (de) 2000-08-10
NO961776D0 (no) 1996-05-02
MY111770A (en) 2000-12-30
RU2139278C1 (ru) 1999-10-10
FI961914A0 (fi) 1996-05-06
SK55996A3 (en) 1996-12-04
US5856346A (en) 1999-01-05
ATE194330T1 (de) 2000-07-15
NO305656B1 (no) 1999-07-05
CZ285691B6 (cs) 1999-10-13
PT726894E (pt) 2000-10-31
CZ127396A3 (en) 1996-09-11
JPH09504542A (ja) 1997-05-06
SK281467B6 (sk) 2001-04-09
PL185099B1 (pl) 2003-02-28
HU215591B (hu) 1999-01-28
IL111127A0 (en) 1994-12-29
GR3034469T3 (en) 2000-12-29
EP0726894B1 (en) 2000-07-05
DE69425152T2 (de) 2001-03-22
NO961776L (no) 1996-05-02
JP3712209B2 (ja) 2005-11-02
FR12C0053I2 (fr) 2013-08-16
FI961914A (fi) 1996-05-06
HK1013292A1 (en) 1999-08-20
HU9601187D0 (en) 1996-07-29
HUT75316A (en) 1997-05-28
EP0726894A1 (en) 1996-08-21
BR9407946A (pt) 1996-11-26
IS1674B (is) 1997-12-31
UA45959C2 (uk) 2002-05-15
TW279859B (ja) 1996-07-01
PL314128A1 (en) 1996-08-19
CN1049428C (zh) 2000-02-16
NZ275915A (en) 1997-04-24
WO1995012578A1 (en) 1995-05-11
CN1137269A (zh) 1996-12-04
FI110429B (fi) 2003-01-31
IL111127A (en) 2000-11-21
ZA947570B (en) 1995-05-29
LU92209I2 (fr) 2013-08-23
SA94150250B1 (ar) 2006-03-01
CA2174969A1 (en) 1995-05-11
KR100331663B1 (ko) 2002-09-26
CA2174969C (en) 2005-05-17

Similar Documents

Publication Publication Date Title
EG20539A (en) Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure
IL104740A0 (en) Hypolipidaemic compounds,their preparation and pharmaceutical compositions containing them
NZ238206A (en) The stereoselective preparation of phenylisoserine derivatives and the use of such derivatives in preparing baccatin-iii and 10-deacetylbaccatin-iii derivatives
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
GR3017766T3 (en) Process for preparing sertraline.
HUT64309A (en) Process for production pharmaceutical preparations having benzazepine compounds as effective substance and the new effective substance
IL113002A0 (en) 4 - methylene - 2H - chromen - 3(4H)- one derivatives their preparation and use
GB9306899D0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
ES8207519A1 (es) Procedimiento para la obtencion de derivados del imidazol.
HUT75343A (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing the said compds.
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
ES8307798A1 (es) Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol.